Skip to main content

Clearing the Air Around Cannabidiol: Addressing Medical Applications, OTC Products, and Misunderstandings

Tracking # 20-1315060

Free

4.5 (2 ratings)
Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

The goal of this educational activity is to provide pharmacists with a clear understanding of the distinctions between Cannabis-derived substances such as cannabidiol (CBD) and their mechanisms and applications in medicine, including epilepsy syndromes and other neuropsychiatric conditions, as well as the differences in prescription and over-the-counter products to enable pharmacists to better educate patients and counsel colleagues.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Pharmacy

Pharmacist

1h General

Disclosure statements

Dr. Schwander has no actual or potential conflicts of interest in relation to this program.

The clinical/legal reviewer Gerald Gianutsos, PhD, JD has no actual or potential conflicts of interest in relation to this program.

The medical writer, Thomas Cook, RPh, PhD, has disclosed that he is employed as a remote dispensary pharmacist at The Apothecarium, a medical cannabis dispensary operated by TerrAscend, a North American cannabis company.

Statements, views, and opinions expressed in this monograph belong solely to the medical writer and faculty. They do not reflect the views, opinions, or positions of their employers.

Susanne Kwas, MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

All relevant financial relationships have been mitigated.

Learner Feedback